Both in Pharmaceuticals
PepGen vs AN2 Therapeutics
Over the past year PEPG returned −46.4% and ANTX returned +262.6%; their daily moves had a correlation of 0.03.
PEPG −46.4% ANTX +262.6%Growth of $1, one year, split-adjusted
| Metric | PEPG | ANTX |
|---|---|---|
| Price | $2.43 | $4.17 |
| Market cap | $168.3M | $157.4M |
| Today | +3.40% | −4.14% |
| 1 month | +3.0% | −25.7% |
| 6 months | +25.9% | −11.1% |
| Year to date | −62.7% | +265.8% |
| 1 year | −47.9% | +239.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $117.2M | $78.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | 75.1% |
| Short % of float | 9.6% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).